A screening programme for low testosterone championed by US Defense Secretary Pete Hegseth may flag up to 25 percent of the Army, according to an analysis reported by Ars Technica.
The number is the story. Testosterone deficiency is a real clinical condition, but the threshold that defines it is not a bright line: reference ranges differ between guidelines, they shift with age and time of day, and a single measurement is expected to vary. Widen the cut-off and the share of any healthy adult male population falling below it grows quickly. At the level described, the programme would not be identifying a fringe of unwell troops — it would be marking roughly one in four soldiers as a patient.
That is why the screening is being described as dubious. A test whose positive rate is measured in double-digit percentages of an entire force tells you far more about the threshold than about the health of the people being tested, and it puts the military in the position of deciding what to do with a quarter of its own personnel — medically, administratively, or simply on paper.
The available reporting does not settle which cut-off produced the 25 percent figure, how many tests a service member must fail before being flagged, whether a diagnosis would affect deployment, retention or fitness evaluations, or what the Department of Defense intends to do with the results.
What is clear is the mismatch between a screening programme and the evidence base behind its threshold. Universal hormone screening of a workforce is an unusual public-health intervention, and its costs land on the people it flags before it produces any treatment.
The data point to watch next is not another estimate, but the Pentagon's own reported flag rate once the screening runs at scale.
